In the Know

Hot Topics in Antitrust: What Counsel and Companies Should be Aware Of
AGG Seminars & Webinars
April 25, 2013

The attorneys of Arnall Golden Gregory's Litigation Practice Group and Antitrust Litigation Practice Team held a complimentary Litigation Series webinar on Thursday, April 25, 2013 from 11:00 am – 12:00 pm EST.

AGG partners Allen I. Hirsch and Jeffrey S. Jacobovitz discussed the following key topics during the one hour presentation:

I. Overview

  • A brief synopsis of the relevant statutes:
    • Sherman §1 
    • Sherman §2 
    • Clayton §3 
    • Clayton §7 '
    • Robinson Patman 
    •  FTC A
  • The Applicable Test
    • Per Se vs. Rule of Reason

II. Criminal Cartel Cases

  • Increasing DOJ Enforcement 
    • Significant increase in jail sentences and fines over the last ten years 
    • Significant increase in international cartel cases and cooperation with international authorities
  • Fines 
    • What does this mean for companies 
  • Jail Sentences 
    • What does this mean for officers of companies 
  • Bid Rigging/Price Fixing 
  • As in-house counsel, what to look for 
  • How to Prevent These Cases 
  • What to do if a Search Warrant is being executed

III. Mergers & Acquisitions 

  • Clayton §7 – “Substantial Likelihood of Lessening Competition” 
  • DOJ/FTC Guideline – Current Climate for Merger Review 
  • Pre-Merger Conduct / “Gun Jumping” 
    • HSR – Filing Requirements / Market Definition

IV. Resale Price Maintenance

  • Pre-Leegin – The Days of Per Se Analysis 
  • Leegin – The Case that Changed It All 
  • Post Leegin – Confusing and Controversial

V. Health Care Enforcement 

  • DOJ/FTC Guidelines 
    • How do they impact on enforcement 
  • Provider Networks and Joint Ventures 
  • Professional Association Activity
  • What are the risks in participation 
  • Hospital Issues 
  • Hatch-Waxman Act 
    • Streamlined procedure for obtaining FDA approval of generic pharmaceuticals 
  • Settlements 
    • FTC and DOJ have challenged settlements as being anticompetitive; 
    • “reverse payments” or “pay for delay” agreements 
  • How to Avoid Government Scrutiny on a Settlement

VI. Intellectual Property 

  • Patent Antitrust Issues 
    • Recent enforcement cases 
    • Causes of action under Section 2
  • Patent Misuse 
    • Does the patent holder have to forfeit its right to enforce the patent 
  • Licensing of IP Rights 
    • Are license agreements contracts within the scope of Section 1 
  • Non-patent IP issues 
    • Copyrights and trademarks 
    • Antitrust counterclaims 
  • Areas of Exposure for In-House Counsel in the IP Area